The results of a recent study that was published in the journal of Circulation, suggest that low-density lipoprotein ...
For those choosing to go vegan, the doctor said, it’s important to “increase soluble fiber, focus on whole foods, which are ...
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...
Increased levels of Low-density lipoprotein (LDL) can put th heart health at risk. Elevated levels of cholesterol can be due to sedentary lifestyle, no physical activity, consuming unhealthy diet, ...
A little more than a month after AstraZeneca jumped into the fray with the purchase of a rival heart drug candidate, Eli ...
Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...
Elevated Remnant Cholesterol tied to increased ASCVD events in Individuals With Diabetes suggests a study published in the ...
The FDA rejected an application from Astellas seeking to change the prescribing label for its eye drug Izervay to allow less ...
Lp (a) is a genetically driven variant of low-density lipoprotein (LDL) cholesterol, that is known to be an independent risk ...
Eli Lilly said the treatment, a once-daily pill called muvalaplin, showed reductions in Lp (a) levels compared to placebo. Injectables are currently in Phase 3 development, but "these are the first ...
Low-density lipoprotein (LDL) cholesterol: We call LDL "bad" cholesterol. Below 100 milligrams per deciliter (mg/dl) is ...
"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...